Disclosure of Compensation Related Costs, Share-based Payments [Text Block] | NOTE 8: STOCKHOLDERS’ EQUITY (DEFICIENCY) a. Composition of common stock capital: Authorized Issued and outstanding Number of shares December 31, December 31, 2016 2015 2016 2015 Stock of $0.001 par value: Common stock 200,000,000 200,000,000 26,821,762 26,069,154 b. Common stock rights: The Company’s Amended and Restated Certificate of Incorporation authorizes the Company to issue 200,000,000 $0.001 The common stock confers upon its holders the right to participate in the general meetings of the Company, to vote at such meetings (each share represents one c. Stock option plans: On December 30, 2005, 2005 “2005 December 31, 2013, 4,713,319 four No 2005 December 31, 2013, 2005 On November 14, 2013, 2013 “2013 1,904,633 2013 2013 January 1, 2016 January 1 four (4%) December 31 2013 five (5%) December 31. January 1, 2016 2017, 2013 1,042,766 1,072,870 2013 four 2013 A summary of employees’ stock options activities during the year ended December 31, 2016 Year ended Number Weighted Aggregate Weighted Options outstanding at the beginning of the year 2,782,560 $ 14.026 $ 21,337 6.246 Granted 135,000 $ 16.870 Exercised (445,535 ) $ 5.901 Forfeited (83,677 ) $ 27.126 Options outstanding at the end of the period 2,388,348 $ 15.243 $ 30,025 5.861 Vested and expected to vest 2,331,800 $ 15.074 $ 29,689 5.806 Options exercisable at the end of the period 1,752,416 $ 12.583 $ 26,473 5.119 A summary of employees’ stock options activities during the years ended December 31, 2015 2014 Year ended Number Weighted Aggregate Weighted Options outstanding at the beginning of the year 4,080,611 $ 9.697 $ 95,855 6.092 Granted 191,200 $ 28.253 Exercised (1,334,351 ) $ 1.521 Forfeited (154,900 ) $ 25.265 Options outstanding at the end of the period 2,782,560 $ 14.026 $ 21,337 6.246 Vested and expected to vest 2,677,503 $ 13.623 $ 21,284 6.156 Options exercisable at the end of the period 1,794,249 $ 8.841 $ 20,496 5.035 The weighted average grant date fair values of options granted during the years ended December 31, 2016, 2015 2014 $16.870, $28.637 $14.087, Year ended Number Weighted Aggregate Weighted Options outstanding at the beginning of the year 3,233,235 $ 4.033 $ 65,723 5.700 Granted 1,111,940 $ 25.077 Exercised (213,174 ) $ 1.663 Forfeited (51,390 ) $ 19.449 Options outstanding at the end of the period 4,080,611 $ 9.697 $ 95,855 6.092 Vested and expected to vest 3,965,741 $ 9.318 $ 94,581 6.000 Options exercisable at the end of the period 2,620,454 $ 2.638 $ 79,117 4.359 The aggregate intrinsic value in the table above represents the total intrinsic value that would have been received by the option holders had all option holders exercised their options on the last date of the exercise period. Total intrinsic value of options exercised for the years ended December 31, 2016, 2015 2014 $9,418, $27,885 $4,800, December 31, 2016 2015, $3,380 $11,779, 2005 2013 1.774 2.416 The options outstanding as of December 31, 2016 Range of Options Weighted Weighted Options Weighted Weighted $0.901 - 1.576 710,562 2.482 $ 1.317 710,562 2.482 $ 1.317 $6.230 - 8.800 89,373 4.963 $ 6.953 89,373 4.963 $ 6.953 $12.470 - 16.870 442,507 7.078 $ 13.812 279,863 6.163 $ 12.470 $19.510 - 21.660 546,959 7.622 $ 21.205 307,302 7.558 $ 21.200 $22.010 - 24.230 295,513 7.299 $ 22.278 191,891 7.289 $ 22.316 $29.88 154,200 8.145 $ 29.880 70,684 8.145 $ 29.880 $39.86 149,234 7.225 $ 39.860 102,741 7.225 $ 39.860 2,388,348 5.861 $ 15.243 1,752,416 5.119 $ 12.583 The options outstanding as of December 31, 2015 Range of Options Weighted Weighted Options Weighted Weighted $0.901 - 1.576 978,178 2.923 $ 1.224 978,178 2.923 $ 1.224 $6.230 - 8.800 145,693 5.92 $ 6.786 137,391 5.895 $ 6.785 $12.47 378,149 7.177 $ 12.470 261,065 7.159 $ 12.470 $19.510 - 21.660 640,743 8.609 $ 21.219 211,571 8.477 $ 21.237 $22.010 - 24.230 309,222 8.298 $ 22.293 127,326 8.280 $ 22.365 $29.88 154,200 9.148 $ 29.880 — 0.000 $ 0.000 $39.86 176,375 8.227 $ 39.860 78,718 8.227 $ 39.860 2,782,560 6.246 $ 14.026 1,794,249 5.035 $ 8.841 d. Options issued to consultants: The Company’s outstanding options granted to consultants for services as of December 31, 2016 Issuance date Options for Exercise price Options Exercisable (number) (number) February 2013 1,500 $ 12.470 1,344 February 2023 August 2013 4,188 $ 21.140 3,104 August 2023 October 2013 750 $ 24.230 547 October 2023 March 2014 13,100 $ 39.860 8,187 March 2024 May 2014 6,850 $ 22.010 3,704 May 2024 November 2014 10,246 $ 21.660 4,364 November 2024 May 2015 5,250 $ 19.510 1,750 May 2025 February 2016 2,500 $ 16.870 — February 2026 44,384 23,000 The Company’s outstanding options granted to consultants for services as of December 31, 2015 Issuance date Options for Exercise price Options Exercisable (number) (number) February 2013 3,000 $ 12.470 2,125 February 2023 August 2013 5,000 $ 21.140 2,917 August 2023 October 2013 823 $ 24.230 479 October 2023 March 2014 14,438 $ 39.860 6,422 March 2024 May 2014 8,700 $ 22.010 3,444 May 2024 August 2014 219 $ 21.000 354 August 2024 November 2014 12,000 $ 21.660 3,250 November 2024 May 2015 5,250 $ 19.510 — May 2025 49,430 18,991 e. Restricted stock units: The following provides a summary of the restricted stock unit activity for the Company for the year ended December 31, 2016: Number of Weighted- Outstanding as of January 1, 2016 643,506 $ 23.38 Granted 1,038,044 $ 19.67 Vested (199,074 ) $ 22.82 Forfeited (83,349 ) $ 20.21 Unvested as of December 31, 2016 1,399,127 $ 19.96 The following provides a summary of the restricted stock unit activity for the Company for the year ended December 31, 2015: Number of Weighted- Outstanding as of January 1, 2015 27,470 $ 21.00 Granted 685,065 $ 23.30 Vested (36,789 ) $ 19.90 Forfeited (32,240 ) $ 23.56 Unvested as of December 31, 2015 643,506 $ 23.38 f. 2015 On May 5, 2015, 2015 March 19, 2015. June 30, 2015. 15% 85% first 500,000 January 1, 2016, January 1 one (1%) December 31 two (2%) December 31, 400,000 January 1, 2016 2017, 21,383 158,695 June 30, 2025; g. Stock-based compensation expense for employees and consultants: The Company recognized non-cash stock-based compensation expense in the consolidated statements of operations as follows (in thousands): Year ended 2016 2015 2014 Cost of revenues $ 699 $ 419 $ 192 Research and development 3,052 1,954 1,198 Sales and marketing 6,104 3,041 2,478 General and administrative 3,083 2,380 796 Total $ 12,938 $ 7,794 $ 4,664 |